Jazz Pharmaceuticals JAZZ Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's inventories?
- Jazz Pharmaceuticals (JAZZ) reported inventories of $437.5M in Q1 2026.
- How has Jazz Pharmaceuticals's inventories changed year-over-year?
- Jazz Pharmaceuticals's inventories decreased by 11.2% year-over-year, from $492.78M to $437.5M.
- What is the long-term trend for Jazz Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's inventories has grown at a 34.3% compound annual growth rate (CAGR), from $95.4M to $417M.
- What does inventories mean?
- The total value of all products and materials the company has in stock.
- How do you interpret inventories?
- An increase may signal anticipated demand or supply chain inefficiencies, while a decrease could indicate strong sales or potential stock-out risks.
- How does inventories compare across companies?
- Highly dependent on the product lifecycle and manufacturing complexity; peers often track inventory turnover ratios.